Novagali Pharma Presents Phase III Clinical Trial of Vekacia(R) for Vernal Keratoconjunctivitis
Novagali Pharma, an emerging pharmaceutical company Presents Phase III clinical study of Vekacia(R) in children suffering from Vernal Keratoconjunctivitis (VKC)